Panel Discussion: Evolving Regulatory Expectations for Emerging Market Approvals

Duration - 59 Minutes

Price - INR-2000 / USD-70
Book Now   Enquire Now  

About the course

  • Appreciation of pharma product in Emerging Markets
  • Broad understanding of the evolution of the regulatory model in these countries
  • Practical points of consideration when building and executing regulatory strategies for Emerging Markets

Speaker Profile

Stephen Murby

Board Member
Alliance for Safe Biologic Medicines

Sukanya Choudhury

Executive Vice President - Regulatory Affairs
GSK Pharmaceuticals, India

Dr. Nagendran Irukulapati

Sr. Vice President – Global Regulatory Affairs
Aurobindo Pharma

Santosh Savarkar

Former Director Regulatory Affairs
Emcure Pharmaceuticals

Website by: Xpoteck